Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2022 | Potential of iPSCs as a useful model in Alzheimer’s disease research

Richard Elsworthy • 1 Mar 2022
ARUK 2022
Alzheimer’s Disease Dementia

Richard Elsworthy, PhD, University of Birmingham, Birmingham, UK, compares the use of induced pluripotent stem cell (iPSC) cultures to animal models and cell lines in Alzheimer’s disease research. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.

More from Richard Elsworthy

1:41
Exercise in the prevention of dementia
Richard Elsworthy • 1 Mar 2022
2:05
Investigating links between anti-depressants and Alzheimer’s pathology
Richard Elsworthy • 1 Mar 2022

Related Videos

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:19
Current projects from Alzheimer’s Disease International
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals